These findings demonstrated that GOLM1 and FAM49B genes might be used as potential biomarkers to determine the development of HNSCC; moreover, GOLM1 and FAM49B can possibly be verified as prognostic indicators of HNSCC patients. The gene discussed is GOLM1; the disease is head and neck squamous cell carcinoma.